Bayer Cares Foundation promotes sustainable growth by supporting social impact pioneers with grants totaling EUR 1 million

Two years’ support for five social impact start-ups in healthcare and nutrition / Visionary entrepreneurs helping to improve millions of people’s lives / Grant for handheld breast cancer screening device developed in the USA and being piloted in Brazil ...

Bayer receives approval of new treatment regimen for Eylea® in the EU

New treatment regimen could offer patients with neovascular age-related macular degeneration (AMD) extended proactive dosing already in the first year, while delivering strong visual gains / Data from ALTAIR study demonstrate sustainability of new approach in 57% of patients who extended their treatment interval to 12 weeks or more ...

LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit

Significant step to bolster LEO Pharma’s role as a leading global dermatology company with its goal of helping 125 million patients by 2025 ...

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery disease

Positive CHMP opinion based on data from the largest Phase III rivaroxaban study, COMPASS / Once approved, rivaroxaban will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk for ischaemic events ...

Bayer to appeal against recent General Court verdict on neonicotinoids

Bayer receives approval for Kovaltry® in China for the treatment of children and adults with Hemophilia A

Young scientists experimenting on health and food science topics at Bayer Science Teens Camp in the U.S.

International exchange: Pupils from Germany, India, Africa and the U.S. taking part in two-week, hands-on seminar focusing on life science, medical health and food science topics / Bayer partnering with renowned Center for STEM Learning at University of Colorado in Boulder ...

Bayer continues commitment to improving feline medicine and health with symposium at ISFM congress

Bayer recently supported the International Society of Feline Medicine (ISFM) 2018 European Congress, with platinum sponsorship of the event / A symposium organised by Bayer at the Congress, saw leading experts discuss the latest information on two feline infectious diseases / Key messages included how to minimise the risk of a mycoplasmal infection and the threat of feline leishmaniosis ...

XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation

Outcomes from real-world patients with atrial fibrillation (AF) confirm low bleeding and low stroke rates for Xarelto ...

Bayer Animal Health and Mitsui Chemicals Agro sign global license agreement

Bayer to expand its strong parasiticide portfolio for companion animals with new compounds derived from MCAG’s chemical library ...